Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A | P11388 | 2/20 | 0.63 |
| ▸ | AKR1C3 | P42330 | 12/20 | 0.61 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.61 |
| ▸ | POLM | Q9NP87 | 1/20 | 0.47 |
| ▸ | POLK | Q9UBT6 | 1/20 | 0.47 |
| ▸ | POLL | Q9UGP5 | 1/20 | 0.47 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27214652 | 1.00 | TOP2A (0.63) | TOP2AAKR1C3AKR1C2POLMPOLK | |
| SCHEMBL30886669 | 1.00 | TOP2A (0.63) | TOP2AAKR1C3AKR1C2POLMPOLK | |
| SCHEMBL27214671 | 1.00 | TOP2A (0.63) | TOP2AAKR1C3AKR1C2POLMPOLK | |
| SCHEMBL27214654 | 0.98 | TOP2A (0.65) | TOP2AAKR1C3AKR1C2POLMPOLK | |
| SCHEMBL30886656 | 0.98 | TOP2A (0.65) | TOP2AAKR1C3AKR1C2POLMPOLK | |
| SCHEMBL27231190 | 0.98 | TOP2A (0.65) | TOP2AAKR1C3AKR1C2POLMPOLK | |
| SCHEMBL31722977 | 0.98 | TOP2A (0.65) | TOP2AAKR1C3AKR1C2POLMPOLK | |
| SCHEMBL27231191 | 0.98 | TOP2A (0.65) | TOP2AAKR1C3AKR1C2POLMPOLK | |
| SCHEMBL5452842 | 0.95 | TOP2A (0.72) | TOP2AAKR1C3AKR1C2ALOX15KDM4E | |
| SCHEMBL5452849 | 0.95 | TOP2A (0.72) | TOP2AAKR1C3AKR1C2ALOX15KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606453-B2 | Method for making and using anticorrosive material | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2026-04-21 | — | — | US | claimed |
| US-12466741-B2 | Method to synthesize silver nanohybrid material | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-11-11 | — | — | US | claimed |
| US-12606453-B2 | Method for making and using anticorrosive material | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2026-04-21 | — | — | US | disclosed |
| US-12466741-B2 | Method to synthesize silver nanohybrid material | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606453-B2 | Method for making and using anticorrosive material | ELL, CA3, PCCA | TOP2A 316/4885AKR1C3 1520/4885AKR1C2 1616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.